Search

Your search keyword '"Antiviral agents -- Complications and side effects"' showing total 457 results

Search Constraints

Start Over You searched for: Descriptor "Antiviral agents -- Complications and side effects" Remove constraint Descriptor: "Antiviral agents -- Complications and side effects"
457 results on '"Antiviral agents -- Complications and side effects"'

Search Results

2. Reports from University of Toronto Add New Study Findings to Research in Antivirals (The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine)

3. New Antivirals Study Findings Have Been Reported from Pfizer (Physiologically Based Pharmacokinetic Modeling of the Drug-drug Interaction Between Cyp3a4 Substrate Glasdegib and Moderate Cyp3a4 Inducers In Lieu of a Clinical Study)

4. Data from Azienda Sanitaria Universitaria Update Knowledge in COVID-19 (Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice)

5. Studies from University of Sorocaba Yield New Data on HIV/AIDS (Rates of adverse events of antiretroviral therapy in women living with HIV/AIDS: a systematic review and meta-analysis)

6. Data on Cytomegalovirus Published by a Researcher at Nagoya University Graduate School of Medicine (Proteomic analysis reveals novel plasma biomarkers for neurological complications in patients with congenital cytomegalovirus infection)

7. University of Medical Sciences Researcher Has Provided New Data on Insulin Resistance (Evaluating Antiretroviral Therapy-Induced Insulin Resistance Syndrome Using The Homeostasis Model Assessment Method: An Important Global Clarion Call For ...)

8. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study

9. Behavioural and social science research

10. New Pregnancy Complications Findings from University of Oxford Described (Perinatal Outcomes Associated With Combination Antiretroviral Therapy Compared With Monotherapy)

11. SPOTLIGHT ON CDER SCIENCE: A NOVEL MOUSE MODEL OFFERS INSIGHTS ABOUT HYPERSENSITIVITY TO AN HIV DRUG

12. New Hyponatremia Study Findings Have Been Published by Researchers at Kaohsiung Chang Gung Memorial Hospital (A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant ...)

13. Data on Hepatitis C Virus Described by a Researcher at Ankara City Hospital (The changing non-invasive fibrosis index value in patients with hepatitis C treated with direct-acting antiviral agents)

14. Predictors of Weight Gain, Metabolic Complications in Patients With HIV on Antiretroviral Therapy

15. Researchers' from University of Cambridge Report Details of New Studies and Findings in the Area of Vaccinia (Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection)

16. Data on Cirrhosis Discussed by Researchers at Foundation Policlinico University A Gemelli IRCCS (Dynamics of Liver Stiffness Predicts Complications In Patients With Hcv Related Cirrhosis Treated With Direct-acting Antivirals)

17. Reports Summarize Chronic Hepatitis C Virus Study Results from Ain Shams University (Impact of direct-acting antiviral therapy on metabolic profiles and adiponectin serum level in different categories of patients with chronic hepatitis C ...)

18. New Findings from Atlanta Department of Veterans Affairs Medical Center Describe Advances in Infectious Diseases and Conditions (Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due To Natural Aging In a Mouse Model)

19. Hepatitis C Virus Positivity Linked to Schizophrenia Development

20. Data Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell's Omisirge[R] (omidubicel-onlv)

21. Why hunger is driving thousands to abandon the drugs that keep them alive; Starving HIV and TB patients are shunning their medication as the side effects on an empty stomach are too severe

22. Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana

23. Reports from Fudan University Highlight Recent Research in Antivirals (A Novel Method for Predicting the Human Inherent Clearance and Its Application in the Study of the Pharmacokinetics and Drug-Drug Interaction between Azidothymidine and ...)

24. IPC sounds safety alert against hepatitis C drug sofosbuvir

25. Reports from Shanghai University of Traditional Chinese Medicine Highlight Recent Findings in Influenza A Virus (Inhibition of Drug-metabolizing Enzymes By Jingyin Granules: Implications of Herb-drug Interactions In Antiviral Therapy)

26. Government urges take up of Covid antivirals as almost 500,000 in Australian stockpile near expiry date; Health minister says Coalition allowed drugs that can prevent severe cases and hospitalisation to 'gather dust' in storageWhy are there so many Omicron subvariants and why have BA.4 and BA.5 taken hold?Covid data tracker: cases, deaths, hospitalisations and vaccinationGet our free news app, morning email briefing and daily news podcast

27. Calls to expand access to Covid antivirals in Australia splits experts and doctors; Health minister encourages Paxlovid and Lagevrio use, but peak GP body cautions drugs can have side-effects if taken with some other drugsGet our free news app ; get our morning email briefing

28. Drugs to prevent COVID-19 complications plentiful in Wisconsin, officials say

29. Investigators at Hainan Medical University Discuss Findings in Zika Virus (Targeting the Inositol-requiring Enzyme-1 Pathway Efficiently Reverts Zika Virus-induced Neurogenesis and Spermatogenesis Marker Perturbations)

30. Data on Antivirals Reported by Researchers at University of Florida (Quantitative Benefit-risk Assessment of P-gp-mediated Drug-drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers In Patients With Renal Impairment)

31. Research from Vancouver General Hospital Yields New Findings on Hepatitis (Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents)

32. Data on Chronic Hepatitis C Virus Detailed by Researchers at Aix-Marseille University (Drug-drug Interactions Potential of Direct-acting Antivirals for the Treatment of Chronic Hepatitis C Virus Infection)

33. Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

34. Pfizer Reports Additional Data on PAXLOVID[TM] Supporting Upcoming New Drug Application Submission to U.S. FDA

35. Studies from Stanford University Further Understanding of Male Kidney Diseases and Conditions (Association of Direct-acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality In Patients With Chronic Hepatitis C)

36. HIV, antiretroviral therapy and non‐communicable diseases in sub‐Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016

37. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

38. Cardiopulmonary dysfunction in perinatally HIV‐infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort

39. Screening of diabetes mellitus among people living with HIV

41. Reports from H.M. Abdullatif and Co-Researchers Add New Data to Findings in Hepatitis C Virus (Drug-Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection)

42. New Non-Alcoholic Fatty Liver Disease Findings from Hebei Medical University Outlined (Adverse Effect of Nonalcoholic Fatty Liver Disease On the Therapeutic Response In Patients With Chronic Hepatitis B)

43. Emory University School of Medicine Researchers Further Understanding of HIV/AIDS (Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations)

45. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy

46. Review of hepatitis B therapeutics

47. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from AASERT study

48. Taking side effects into account for HIV medication

49. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti

50. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

Catalog

Books, media, physical & digital resources